These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 3313733

  • 1. Oral vaccine against cholera prepared from Vibrio cholerae antigen(s).
    Chaicumpa W, Chaisri U, Tapchaisri P, Chongsa-Nguan M, Pongponratn E.
    Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):142-8. PubMed ID: 3313733
    [Abstract] [Full Text] [Related]

  • 2. Cell-bound haemagglutinin (CHA) of V. cholerae 01 as protective antigen.
    Chaicumpa W, Boonthum A, Kalumbaheti T, Tapchaisri P.
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):407-13. PubMed ID: 6523176
    [Abstract] [Full Text] [Related]

  • 3. Antibodies against Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in the intestinal fluid during convalescence.
    Chongsa-Nguan M, Chaicumpa W, Kalambaheti T, Surachedchai Y, Thanungkul B.
    Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):33-8. PubMed ID: 3660066
    [Abstract] [Full Text] [Related]

  • 4. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A, Giraldo A, Castañeda E, Martínez M, de la Hoz F, Rivas F, Depetris A, Svennerholm AM, Sack DA.
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity of two formulations of oral cholera vaccines in Thai volunteers.
    Chongsa-nguan M, Chaicumpa W, Ruangkunaporn Y, Looareesuwan S.
    Vaccine; 1991 Jan; 9(1):53-9. PubMed ID: 2008802
    [Abstract] [Full Text] [Related]

  • 6. Construction of an engineered bivalent vaccine strain consisting of Vibrio cholerae CT-B and LPS-O antigens.
    Yu X, Ma Q.
    Chin J Biotechnol; 1994 Jan; 10(4):225-32. PubMed ID: 7780018
    [Abstract] [Full Text] [Related]

  • 7. CpG DNA, liposome and refined antigen oral cholera vaccine.
    Leelawongtawon R, Somroop S, Chaisri U, Tongtawe P, Chongsa-nguan M, Kalambaheti T, Tapchaisri P, Pichyangkul S, Sakolvaree Y, Kurazono H, Hayashi H, Chaicumpa W.
    Asian Pac J Allergy Immunol; 2003 Dec; 21(4):231-9. PubMed ID: 15198341
    [Abstract] [Full Text] [Related]

  • 8. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM.
    Int Arch Allergy Appl Immunol; 1975 Dec; 49(4):434-52. PubMed ID: 808500
    [Abstract] [Full Text] [Related]

  • 9. Vibriocidal antibody and antibodies to Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in Thai population.
    Chongsa-nguan M, Chaicumpa W, Kalambaheti T, Soejoedi H, Luxananil P, Swasdikosa S, Thanasiri P, Mayurasakorn S.
    Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):558-66. PubMed ID: 3576285
    [Abstract] [Full Text] [Related]

  • 10. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S, Ahmed T, Mannoor K, Begum YA, Bardhan PK, Sack RB, Sack DA, Svennerholm AM, Holmgren J, Qadri F.
    Vaccine; 2009 Feb 25; 27(9):1386-92. PubMed ID: 19146897
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF, Ionescu MD, Palade R, Balotescu C, Becheanu G, Dima SV.
    Roum Arch Microbiol Immunol; 2001 Feb 25; 60(1):27-54. PubMed ID: 11850896
    [Abstract] [Full Text] [Related]

  • 12. Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulation.
    Borde A, Larsson A, Holmgren J, Nygren E.
    Eur J Pharm Biopharm; 2011 Nov 25; 79(3):508-18. PubMed ID: 21757004
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
    Cryz SJ, Fürer E, Germanier R.
    Dev Biol Stand; 1983 Nov 25; 53():67-72. PubMed ID: 6873478
    [Abstract] [Full Text] [Related]

  • 14. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE, Lucas C, Bleakley CR.
    Vaccine; 2004 Jun 02; 22(17-18):2137-45. PubMed ID: 15149770
    [Abstract] [Full Text] [Related]

  • 15. Murine immune responses to Salmonella lipopolysaccharide: oral administration of whole bacteria to C3H/HeJ mice induces secondary anti-LPS responses, especially of the IgA isotype.
    Jirillo E, Kiyono H, Michalek SM, McGhee JR.
    J Immunol; 1984 Apr 02; 132(4):1702-11. PubMed ID: 6366051
    [Abstract] [Full Text] [Related]

  • 16. Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.
    Losonsky GA, Tacket CO, Wasserman SS, Kaper JB, Levine MM.
    Infect Immun; 1993 Feb 02; 61(2):729-33. PubMed ID: 8423098
    [Abstract] [Full Text] [Related]

  • 17. Traffic of antibody-secreting cells after immunization with a liposome-associated, CpG-ODN-adjuvanted oral cholera vaccine.
    Somroop S, Tongtawe P, Chaisri U, Tapchaisri P, Chongsa-nguan M, Srimanote P, Chaicumpa W.
    Asian Pac J Allergy Immunol; 2006 Dec 02; 24(4):229-38. PubMed ID: 17348246
    [Abstract] [Full Text] [Related]

  • 18. Construction of a Salmonella typhimurium vaccine strain expressing Vibrio cholera CT-B and LPS-O antigen.
    Chen D, Ma Q.
    Chin J Biotechnol; 1997 Dec 02; 13(1):43-50. PubMed ID: 9376506
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.
    Roy N, Barman S, Ghosh A, Pal A, Chakraborty K, Das SS, Saha DR, Yamasaki S, Koley H.
    FEMS Immunol Med Microbiol; 2010 Oct 02; 60(1):18-27. PubMed ID: 20528929
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of liposome-associated oral cholera vaccine prepared from combined Vibrio cholerae antigens.
    Chaicumpa W, Parairo JR, New RC, Pongponratn E, Ruangkunaporn Y, Tapchaisri P, Chongsa-nguan M.
    Asian Pac J Allergy Immunol; 1990 Dec 02; 8(2):87-94. PubMed ID: 2091663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.